期刊文献+

心肌梗死四项的指标水平在急性心肌梗死患者血中之联合表达 被引量:2

Value of cardiac troponin I,creatine kinase isoenzyme-MB myoglobin and B brain natriuretic peptide precursor in diagnosis of acute myocardial infarction
原文传递
导出
摘要 目的探讨全血中心肌肌钙蛋白I(cTnI),肌酸激酶同工酶-MB(CK-MB),肌红蛋白(Myo)和B型脑钠肽前体(NT-proBNP)的联合检测在急性心肌梗死诊断中的应用价值。方法选取河南省人民医院确诊为急性心肌梗死(AMI)的病人102例设为实验组,另外选取健康人102例,设为对照组。检测两组受试者全血中cTnI,Myo,CK-MB及NT-proBNP的表达,对比两组的结果,并对比联合检测和单项检测的结果。结果实验组的cTnI,Myo,CK-MB及NT-proBNP的表达均高于对照组(P<0.05),且这些指标的联合检测阳性率高于单项检测。结论急性心肌梗死的患者全血中cTnI,Myo,CK-MB及NT-proBNP的联合检测有利于提高疾病诊断的准确率,值得在临床推广。 Objective To explore the value of cardiac troponin I(cTnl),creatine kinase isoenzyme-MB(CK-MB),myoglobin(Myo)and B brain natriuretic peptide precursor(NT-proBNP)in the diagnosis of acute myocardial infarction.Methods 102 patients diagnosed with acute myocardial infarction(AMI)were selected as the experimental group,and 102 healthy patients were selected as the control group.The expression of cTnl,Myo,CK-MB and NT-proBNP in whole blood was compared the results and the results of the combined and individual tests.Results The expression of cTnI,Myo,CK-MB and NT-proBNP in the experimental group was higher than that in the control group(P<0.05),and the positive rate of these indexes was higher than that of the individual test.Conclusion The combined detection of cTnI,Myo,CK-MB and NT-proBNP in whole blood of patients with acute myocardial infarction is beneficial to improve the accuracy of disease diagnosis and should be worth popularizing in clinical practice.
作者 万震 田文倩 范砚茹 WAN Zhen;TIAN Wen-qian;FAN Yan-ru(Henan Provincial Peoples Hospital,Zhengzhou 450000,China)
出处 《医药论坛杂志》 2023年第5期106-109,共4页 Journal of Medical Forum
  • 相关文献

参考文献14

二级参考文献107

  • 1包如彬,张帅帅.全血肌红蛋白、心肌肌钙蛋白Ⅰ联合超敏C反应蛋白对老年急性心肌梗死诊断的临床价值[J].中西医结合心血管病电子杂志,2019,0(35):101-101. 被引量:2
  • 2陈明,戴红.CTnI CK-MB和hs-CRP在急性心肌梗死早期诊断中的价值[J].安徽医学,2013,34(10):1481-1483. 被引量:13
  • 3宁宪嘉,王景华,李志尊.天津市城乡居民脑卒中流行病学调查6年前瞻性研究[J].中华流行病学杂志,1995,16(5):281-284. 被引量:5
  • 4MURRAY CJL, LOPEZ AD. Measuring the Global Burden of Disease [ J]. New England Journal of Medicine, 2013, 369 (5) :448-457.
  • 5FEIGIN, VL, KRISHNAMURTHI RV, PARMAR P, et al. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study [ J ]. Neuroepideroiology, 2015, 45 (3) : 161-176.
  • 6Global Burden of Disease Study 2013. Global Burden of Disease Study 2013 ( GBD 2013 ) Results by Location, Cause, and Risk Factor. Seattle, United States: Institute for Health Metrics and Evaluation ( IHME), 2016.
  • 7KRISHNAMURTHI RV, MORAN AE, FEIGIN VL, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study[ J]. Neuroepidemiology, 2015, 45 (3) : 190-202.
  • 8KRISHNAMURTHI RV, DEVEBER G, FEIGIN ~L, et al. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0 ~ 19 Years: Data from the Global and Regional Burden of Stroke 2013 [ J]. Neuroepidemiology, 2015, 45 (3) : 177-189.
  • 9BARKER-COLLO S, BENNETT DA, KRISHNAMURTHI RV, et al. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013 [ J]. Neuroepidemiology, 2015, 45(3) :203-214.
  • 10FEIGIN VL,MENSAH GA, NORRVING B, et al. Atlas of the Global Burden of Stroke ( 1990-2013 ) : The GBD 2013 Study [ J ]. Neuroepidemiology, 2015, 45 (3) :230-236.

共引文献495

同被引文献32

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部